Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotechnology Innovation Organization
Pharma
Industry commends Supreme Court's mifepristone ruling
After the Supreme Court’s decision to preserve access to mifepristone, leaders from across the industry are weighing in with their support.
Fraiser Kansteiner
Jun 14, 2024 2:42pm
AbbVie-FutureGen, Takeda, Kyowa Kirin—Fierce Pharma Asia
Jun 14, 2024 5:00am
BIO CEO talks BIOSECURE Act, trade group reorg
Jun 7, 2024 10:33am
New bill sets decoupling deadline for industry's work with WuXi
May 10, 2024 11:30am
Takeda, Lilly-Innovent, BIO-China—Fierce Pharma Asia
May 10, 2024 9:30am
BIO survey finds sudden CDMO decoupling could harm patients
May 9, 2024 10:00am